Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oxurion NV, a company specializing in ophthalmic therapies, has increased its share capital by EUR 150,000 through Atlas Special Opportunities LLC’s conversion of 6 convertible bonds. This move is part of a EUR 20 million capital commitment from Atlas, facilitating Oxurion’s focus on developing treatments for preserving vision in the elderly, tapping into a market worth USD 3-6 billion. The total number of Oxurion’s outstanding ordinary shares now stands at 2,002,550, which will be the new denominator for calculating shareholding percentages.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
